These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 16552033)

  • 21. Plasmodium vivax gametocyte proteins, Pvs48/45 and Pvs47, induce transmission-reducing antibodies by DNA immunization.
    Tachibana M; Suwanabun N; Kaneko O; Iriko H; Otsuki H; Sattabongkot J; Kaneko A; Herrera S; Torii M; Tsuboi T
    Vaccine; 2015 Apr; 33(16):1901-8. PubMed ID: 25765968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional Conservation of P48/45 Proteins in the Transmission Stages of
    Cao Y; Hart RJ; Bansal GP; Kumar N
    mBio; 2018 Sep; 9(5):. PubMed ID: 30181253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei.
    Reyes-Sandoval A; Sridhar S; Berthoud T; Moore AC; Harty JT; Gilbert SC; Gao G; Ertl HC; Wilson JC; Hill AV
    Eur J Immunol; 2008 Mar; 38(3):732-41. PubMed ID: 18266272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune responses elicited by co-immunization of Plasmodium vivax and P. falciparum MSP-1 using prime-boost immunization strategies.
    Mehrizi AA; Zakeri S; Rafati S; Salmanian AH; Djadid ND
    Parasite Immunol; 2011 Nov; 33(11):594-608. PubMed ID: 21883290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transgenic Plasmodium that expresses HIV-1 Gag elicits immunity and protects mice against vaccinia virus-gag and malarial parasites.
    Jiang B; Qin L; Du Y; Peng N; Chen L; Chen Z; Chen X
    Vaccine; 2010 Nov; 28(50):7915-22. PubMed ID: 20933565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune responses to liver-stage parasites: implications for vaccine development.
    Hollingdale MR; Krzych U
    Chem Immunol; 2002; 80():97-124. PubMed ID: 12058653
    [No Abstract]   [Full Text] [Related]  

  • 27. Plasmodium berghei XAT: protective 155/160 kDa antigens are located in parasitophorous vacuoles of schizont-stage parasite.
    Kobayashi F; Waki S; Niikura M; Tachibana M; Tsuboi T; Torii M; Kamiya S
    Exp Parasitol; 2007 Aug; 116(4):450-7. PubMed ID: 17442306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.
    Rainczuk A; Scorza T; Spithill TW; Smooker PM
    Infect Immun; 2004 Oct; 72(10):5565-73. PubMed ID: 15385453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of DNA vaccine in murine malaria using a full-length cDNA library.
    Shibui A; Ohmori Y; Suzuki Y; Sasaki M; Nogami S; Sugano S; Watanabe J
    Res Commun Mol Pathol Pharmacol; 2001; 109(3-4):147-57. PubMed ID: 11758646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virus-like particles expressing Plasmodium berghei MSP-8 induce protection against P. berghei infection.
    Lee SH; Chu KB; Kang HJ; Basak S; Kim MJ; Park H; Jin H; Moon EK; Quan FS
    Parasite Immunol; 2020 Nov; 42(11):e12781. PubMed ID: 32738150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
    Dobaño C; Rogers WO; Gowda K; Doolan DL
    Immunol Lett; 2007 Aug; 111(2):92-102. PubMed ID: 17604849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced immunogenicity of DNA vaccine plasmids in mixtures.
    Sedegah M; Charoenvit Y; Minh L; Belmonte M; Majam VF; Abot S; Ganeshan H; Kumar S; Bacon DJ; Stowers A; Narum DL; Carucci DJ; Rogers WO
    Gene Ther; 2004 Mar; 11(5):448-56. PubMed ID: 14973538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Boosting of DNA vaccine-elicited gamma interferon responses in humans by exposure to malaria parasites.
    Wang R; Richie TL; Baraceros MF; Rahardjo N; Gay T; Banania JG; Charoenvit Y; Epstein JE; Luke T; Freilich DA; Norman J; Hoffman SL
    Infect Immun; 2005 May; 73(5):2863-72. PubMed ID: 15845492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Plasmodium berghei sexual stage antigen PSOP12 induces anti-malarial transmission blocking immunity both in vivo and in vitro.
    Sala KA; Nishiura H; Upton LM; Zakutansky SE; Delves MJ; Iyori M; Mizutani M; Sinden RE; Yoshida S; Blagborough AM
    Vaccine; 2015 Jan; 33(3):437-45. PubMed ID: 25454088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular vesicles derived from plasmodium-infected red blood cells alleviate cerebral malaria in plasmodium berghei ANKA-infected C57BL/6J mice.
    Lv Y; Wu S; Nie Q; Liu S; Xu W; Chen G; Du Y; Chen J
    Int Immunopharmacol; 2024 May; 132():111982. PubMed ID: 38569430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of C3d on the immunogenicity of gene gun vaccines encoding Plasmodium falciparum and Plasmodium berghei MSP1(42).
    Weiss R; Gabler M; Jacobs T; Gilberger TW; Thalhamer J; Scheiblhofer S
    Vaccine; 2010 Jun; 28(28):4515-22. PubMed ID: 20438877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoprotection by beta-1,3 glucan antigen combination in Plasmodium berghei infection in mice.
    Maheshwari R; Siddiqui MU
    Indian J Med Res; 1989 Nov; 89():396-403. PubMed ID: 2695459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular and humoral immune effector mechanisms required for sterile protection against sporozoite challenge induced with the novel malaria vaccine candidate CelTOS.
    Bergmann-Leitner ES; Legler PM; Savranskaya T; Ockenhouse CF; Angov E
    Vaccine; 2011 Aug; 29(35):5940-9. PubMed ID: 21722682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selection and identification of malaria vaccine target molecule using bioinformatics and DNA vaccination.
    Shuaibu MN; Kikuchi M; Cherif MS; Helegbe GK; Yanagi T; Hirayama K
    Vaccine; 2010 Oct; 28(42):6868-75. PubMed ID: 20709002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of transmission-blocking vaccines simultaneously targeting pre- and post-fertilization antigens in the rodent malaria parasite Plasmodium yoelii.
    Zheng L; Pang W; Qi Z; Luo E; Cui L; Cao Y
    Parasit Vectors; 2016 Aug; 9(1):433. PubMed ID: 27502144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.